Sanofi reaches agreement with Janssen to develop E. coli vaccine
Sanofi announced that it had reached an agreement with Janssen to develop and commercialise a vaccine candidate against extraintestinal pathogenic E. coli. Under the terms of the agreement, both parties will co-fund current and future research and development costs.
POPULAR POSTS
‘The Kardashians’ renewed by Hulu for 20 more episodes
July 26, 2024
Death toll from landslides in Ethiopia could rise to 500
July 26, 2024
The Canadian wildfire has made its way to Jasper
July 26, 2024
LIVE STREAM